Inhibitor Therapeutics, Inc. Additional Paid in Capital, Common Stock
Inhibitor Therapeutics, Inc. (INTI) had Additional Paid in Capital, Common Stock of $54.05 million as of 2023-09-30, per its 10-Q filed 2023-11-13.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AdditionalPaidInCapitalCommonStock · last filed 2023-11-13
- 2023-09-30: Additional Paid in Capital, Common Stock $54.05M.
- 2023-06-30: Additional Paid in Capital, Common Stock $54.05M.
- 2023-03-31: Additional Paid in Capital, Common Stock $54.03M.
- 2022-12-31: Additional Paid in Capital, Common Stock $54.03M.
| Period end | Additional Paid in Capital, Common Stock |
|---|---|
| 2023-09-30 | $54.05M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $54.05M 10-Q · filed 2023-08-11 |
| 2023-03-31 | $54.03M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $54.03M 10-Q · filed 2023-11-13 |
| 2022-09-30 | $50.05M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $50.05M 10-Q · filed 2022-08-12 |
| 2022-03-31 | $50.05M 10-Q · filed 2022-05-13 |
| 2021-12-31 | $50.05M 10-K · filed 2023-03-31 |
| 2021-09-30 | $50.05M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $49.95M 10-Q · filed 2021-08-13 |
| 2021-03-31 | $49.95M 10-Q · filed 2021-05-14 |
| 2020-12-31 | $49.81M 10-K · filed 2022-03-30 |
| 2020-09-30 | $49.69M 10-Q · filed 2020-11-16 |
| 2020-06-30 | $49.44M 10-Q · filed 2020-08-12 |
| 2020-03-31 | $49.40M 10-Q · filed 2020-05-01 |
| 2019-12-31 | $49.38M 10-K · filed 2021-03-26 |
| 2019-09-30 | $49.35M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $49.33M 10-Q · filed 2019-08-12 |
| 2019-03-31 | $49.25M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $49.02M 10-K · filed 2020-03-30 |
| 2018-09-30 | $48.89M 10-Q · filed 2018-11-14 |
| 2018-06-30 | $48.71M 10-Q · filed 2018-07-23 |
| 2018-03-31 | $50.97M 10-Q · filed 2018-05-01 |
| 2017-12-31 | $48.40M 10-K · filed 2019-03-07 |
| 2017-09-30 | $48.39M 10-Q · filed 2017-10-31 |
| 2017-06-30 | $48.38M 10-Q · filed 2017-07-31 |
| 2017-03-31 | $48.32M 10-Q · filed 2017-05-08 |
| 2016-12-31 | $50.17M 10-K · filed 2018-02-16 |
| 2016-09-30 | $43.78M 10-Q · filed 2016-10-31 |
| 2016-06-30 | $42.96M 10-Q · filed 2016-08-12 |
| 2016-03-31 | $37.02M 10-Q · filed 2016-05-13 |
| 2015-12-31 | $36.57M 10-K · filed 2017-02-17 |
| 2015-09-30 | $36.12M 10-Q · filed 2015-11-04 |
| 2015-06-30 | $35.69M 10-Q · filed 2015-08-14 |
| 2015-03-31 | $32.68M 10-Q · filed 2015-05-13 |
| 2014-12-31 | $32.26M 10-K · filed 2016-02-01 |